Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

FactSet Research Systems Inc. Common Stock (NY:FDS)

441.47 +0.04 (+0.01%)
Streaming Delayed Price Updated: 10:41 AM EDT, Jun 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about FactSet Research Systems Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Expert Ratings for FactSet Research Systems
Via Benzinga
Why the quality investor may take a look at NYSE:FDS.
FACTSET RESEARCH SYSTEMS INC (NYSE:FDS) may be suited for quality investing, we'll explore why in this article. 
Via Chartmill
S&P 500 Stocks Experience Puzzling Market Reaction To Positive Earnings: Analysts Investigate
Via Benzinga
Kellogg To Rally Around 27%? Here Are 10 Other Analyst Forecasts For Tuesday
Stephens & Co. boosted the price target for Installed Building Products, Inc. (NYSE: IBP) from $132 to $140. Stephens & Co. analyst Trey Grooms maintained an Equal-Weight rating. Installed Building... 
Via Benzinga
BMO Capital Maintains Market Perform Rating for FactSet Research Systems: Here's What You Need To Know
Via Benzinga
Chipotle To Rally Over 12%? Here Are 10 Other Analyst Forecasts For Friday
Keybanc boosted the price target for Advanced Energy Industries, Inc. (NASDAQ: AEIS) from $105 to $125. Keybanc analyst Steve Barger maintained an Overweight rating. Advanced Energy shares fell 0.6% to... 
Via Benzinga
Why FactSet Research Systems Shares Sliding Today
FactSet Research Systems Inc. (NYSE: FDS) reported  
Via Benzinga
FactSet Research Systems Earnings Preview
Via Benzinga
FactSet Research Systems Falls Into The Buy Zone
Factset Research Systems had a solid quarter and raised the outlook for earnings, sending shares down more than 5% into a buy zone. 
Via MarketBeat
Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private... 
Via Benzinga
Analyst Expectations for FactSet Research Systems's Future
Via Benzinga
Why Tesla Is Ending the Week on a High Note
Tesla may be looking to invest in yet another battery production plant in the U.S. 
Via The Motley Fool
Will Chart Analysts Notice Bad Omen on FactSet Research Systems's Chart
Via Benzinga
What 4 Analyst Ratings Have To Say About FactSet Research Systems
Via Benzinga
FactSet Research Likely To Report Lower Q3 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts
FactSet Research Systems Inc. (NYSE: FDS) is expected to report its financial and operating results for the third quarter fiscal 2023, ending May 31, 2023, before the opening bell on June 22, 2023. 
Via Benzinga
3 Dividend Stocks Yielding About 5% That Should Continue Growing Their Payouts Through at Least 2025
Analysts expect these companies to produce the growing cash flows needed to support rising dividends. 
Via The Motley Fool
3 Dividend Stocks That Should Pay You the Rest of Your Life
These stocks raised their dividends annually for at least a decade and should continue rewarding investors for years. 
Via The Motley Fool
7 Overvalued Value Stocks to Sell Before June 2023
Eventually, even heavily discounted enterprises lose their charm, transitioning to become overvalued value stocks to sell. 
Via InvestorPlace
Microsoft To Rally Around 25%? Here Are 10 Other Analyst Forecasts For Tuesday
Credit Suisse cut the price target for Big Lots, Inc. (NYSE: BIG) from $13 to $7. Credit Suisse analyst Karen Short maintained an Underperform rating. Big Lots shares gained 2.9% to $8.15 in pre-market... 
Via Benzinga
FactSet Slashes FY23 Topline Outlook After Mixed Q2 Results
Via Benzinga
FactSet Research Systems's Earnings Outlook
Via Benzinga
FactSet Is Navigating Financial Sector Pressures With Aggressive Pricing And Margin Expansion, Analyst Weighs In
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 15, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2023
Via Benzinga
4 Dividend Stocks Yielding 4.5%-Plus That Are Great Buys, According to Wall Street
These dividend stocks offer income and upside potential. 
Via The Motley Fool
Verisk Stock Ready To Break Out Of Holding Pattern?
On Wednesday, the Relative Strength Rating for Verisk stock rose to 74. That put it in the top 26% of stocks for price performance. 
Via Investor's Business Daily
These 4 Top Dividend Stocks Have 22% to 47% Upside Potential, According to Wall Street
These stocks offer attractive yields and stock price appreciation potential. 
Via The Motley Fool
Technical Analysis Of Factset Research Systems Inc.
Looking at the FDS chart, we can see it dropped from around $425 to around $385 and now it has been corrected to the lastly traded price of around $401. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For March 28, 2023
Via Benzinga
Earnings Scheduled For March 23, 2023
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is likely to report earnings for its fourth quarter. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.